Part D Plans Offer Broad Drug Access For Dual Eligibles, With Some Exceptions - OIG Study
This article was originally published in The Pink Sheet Daily
Executive Summary
Vytorin, Lunesta and Avapro are among eight drugs that are covered by fewer than 75% of plans available to beneficiaries eligible for both Medicare and Medicaid.